These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37244966)

  • 1. Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis.
    Hajibabaei S; Nafissi N; Azimi Y; Mahdian R; Rahimi-Jamnani F; Valizadeh V; Rafiee MH; Azizi M
    Sci Rep; 2023 May; 13(1):8652. PubMed ID: 37244966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p.
    Yue X; Wu WY; Dong M; Guo M
    Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z; Chang X; Zhu G; Gao X; Chang L
    Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis.
    Sun R; Zhang L
    Biomed Pharmacother; 2019 Mar; 111():1036-1045. PubMed ID: 30841417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
    Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW
    J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
    Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
    Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.
    Liu K; Huang J; Ni J; Song D; Ding M; Wang J; Huang X; Li W
    Cell Cycle; 2017 Mar; 16(6):578-587. PubMed ID: 28346809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of long non-coding RNA MALAT1 inhibits survival and metastasis of esophagus cancer cells by sponging miR-1-3p/CORO1C/TPM3 axis.
    Li Q; Dai Z; Xia C; Jin L; Chen X
    Mol Cell Biochem; 2020 Jul; 470(1-2):165-174. PubMed ID: 32468237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
    Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
    Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L; Zou H; Li B
    Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
    Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Cell Proliferation and Migration by Regulating miR-143-3p and MAGE Family Member A9 (MAGEA9) in Oral Squamous Cell Carcinoma.
    Yu L; Shao X; Huo L; Zhang T
    Med Sci Monit; 2020 Sep; 26():e924187. PubMed ID: 32879299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101.
    Li Z; Xu C; Ding B; Gao M; Wei X; Ji N
    J Neurooncol; 2017 Aug; 134(1):19-28. PubMed ID: 28551849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ-MALAT1 accelerates cell proliferation and epithelial mesenchymal transformation of colorectal cancer through regulating miR-506-3p/KAT6B axis.
    Yang FS; Gong SX; Qiu DD
    Kaohsiung J Med Sci; 2023 Sep; 39(9):862-872. PubMed ID: 37272875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA miR-188-5p as a mediator of long non-coding RNA MALAT1 regulates cell proliferation and apoptosis in multiple myeloma.
    Liu H; Chi Z; Jin H; Yang W
    Bioengineered; 2021 Dec; 12(1):1611-1626. PubMed ID: 33944676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
    Wei S; Wang K; Huang X; Zhao Z; Zhao Z
    Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
    Jiang H; Li X; Wang W; Dong H
    BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA MALAT1 modulates myocardial ischemia-reperfusion injury through the PI3K/Akt/eNOS pathway by sponging miRNA-133a-3p to target IGF1R expression.
    Liu XM; Zhang Z; Zhong J; Li N; Wang T; Wang L; Zhang Q
    Eur J Pharmacol; 2022 Feb; 916():174719. PubMed ID: 34968461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.